Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2016-02-19

Clinical Trial Update: Utilization of NBi in Assessing Luminal INflammaion in IBD (UNBLIND) [NA]

View source ↗

Summary

A clinical trial update describing the use of NBi to assess luminal inflammation in ulcerative colitis; current trial status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: The Leeds Teaching Hospitals NHS Trust | Conditions: Ulcerative Colitis (UC) | NA | Status: UNKNOWN